Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EBT: 2021-2024

Historic EBT for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -$17.7 million.

  • Biofrontera's EBT fell 17.24% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.5 million, marking a year-over-year decrease of 36.90%. This contributed to the annual value of -$17.7 million for FY2024, which is 11.83% up from last year.
  • Latest data reveals that Biofrontera reported EBT of -$17.7 million as of FY2024, which was up 11.83% from -$20.1 million recorded in FY2023.
  • In the past 5 years, Biofrontera's EBT ranged from a high of -$608,000 in FY2022 and a low of -$37.7 million during FY2021.
  • Moreover, its 3-year median value for EBT was -$17.7 million (2024), whereas its average is -$12.8 million.
  • As far as peak fluctuations go, Biofrontera's EBT soared by 98.39% in 2022, and later plummeted by 3,208.72% in 2023.
  • Biofrontera's EBT (Yearly) stood at -$37.7 million in 2021, then skyrocketed by 98.39% to -$608,000 in 2022, then crashed by 3,208.72% to -$20.1 million in 2023, then rose by 11.83% to -$17.7 million in 2024.